Detail akcie genXone Br online

Business Summary: Genxone SA is a Poland-based company, which specializes in NGS (next generation sequencing) and medical diagnostics. The Company is involved in the development and marketing of nanoforming technology in the field of science, business and medicine and cooperates as a commercial partner with Oxford Nanopore Technologies - biotechnological innovation entity.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Genxone SA revenues increased 20% to PLN1.4M. Net loss decreased 21% to PLN1.9M. Revenues reflect Goods & Materials increase from PLN74K to PLN497K. Lower net loss reflects Depreciation & Amortization decrease of 22% to PLN813K (expense), Labor & Related Expenses in SGA decrease of 10% to PLN950K (expense), External Expenses - Third Parties decrease of 14% to PLN657K (expense).